We are monitoring the impact of COVID-19 on Europe Epigenetics Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 1883
Share on
Share on

Europe Epigenetics Market Research Report – Segmented By Product, KITS, Reagents, Research Area, Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis, Share, Size, Growth, Trends, Forecast | 2020 to 2025

Pulished: February, 2020
ID: 1883
Pages: 145

Europe Epigenetics Market Size (2020 to 2025)

The size of the Epigenetics Market in Europe is expected to grow at a CAGR of 13.2% and reach USD 307.66 million in 2025 from USD 165.51 million in 2020.

Factors driving this market growth include increased cancer incidence and prevalence, increased funding for medical R & D, and increased use of epigenetic in non-neoplastic diseases. According to the World Health Organization (WHO), there are more than 3.7 million new cancer cases, and 1.9 million people die each year. Cancer is the second leading cause of death and morbidity in Europe. Epigenetics is used to study changes in gene expression that can be used to diagnose disease. It represents a massive pool of cancer patients driving the epigenetic market.

Europe Epigenetics Market, with the discovery of epigenetic drugs, is presumed to show modest growth during the forecast period. Also, cancer epidemics and advances in technology in epigenetic research are foreseen to drive Europe Epigenetics Market growth. The untapped potential of emerging Europe Epigenetics Market is expected to provide a variety of opportunities for market expansion. Advances in the epigenetic industry are focusing on the detection of methylation markers associated with cancer development. For example, the Geometrics Epi proLung BL Reflex test helps diagnose lung cancer by determining methylation of the SHOX2 biomarker gene.

The prevalence of cancer is rising, and the Europe Epigenetics Market is anticipated to grow. However, factors such as increasing equipment costs are assumed to limit market growth, and the shortage of skilled technicians is suspected of hindering the Europe Epigenetics Market growth.

The European epigenetics market is somewhat competitive and consists of several key players. In terms of market share, several vital players currently dominate the market. With the growing demand for mobile healthcare and the development of ultrasound technology, some small businesses have entered the Europe Epigenetics Market and have a significant share. The intense competition from leading players can suppress the revenue portion of new entrants.

This research report has been segmented & sub-segmented into the following categories:

  • By Product: Enzymes, Instruments & Consumable, KITS and Reagents
  • By Research Area: Developmental Biology, Oncology, and Drug Delivery
  • By Enzymes: DNA-Modifying Enzymes, Protein-Modifying Enzymes, and RNA-Modifying Enzymes
  • By Instruments & Consumables: Mass Spectrometers, Next-Generation Sequencers, qPCR and Sonicators
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe

Based on the research area, the Oncology segment holds the highest share in the market. Still, the drug discovery segment is expected to grow at the highest CAGR during the Forecast Period.

Regionally, Europe is the second-largest market owing to the stable economy and presence of market leaders.

Notable companies in the Europe epigenetics market are Abcam plc., Illumina, Inc., QIAGEN N.V., Merck & Co., New England Biolabs, Inc., Sigma-Aldrich Corporation, Thermo Fisher Scientific, Inc., Active Motif, Diagenode, Inc. and Zymo Research Corporation. 

1.Introduction                                                  

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 Epidemology                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 Product                                        

                                5.1.1 Introduction                           

                                5.1.2 Enzymes                  

                                                5.1.2.1 DNA-Modifying Enzymes              

                                                5.1.2.2 Protein-Modifying Enzymes        

                                                5.1.2.3 RNA-Modifying Enzymes              

                                5.1.3 Instruments & Consumables                           

                                                5.1.3.1 Mass Spectrometers       

                                                5.1.3.2 Next-Generation Sequencers     

                                                5.1.3.3 QPCR     

                                                5.1.3.4 Sonicators            

                                                5.1.3.5 Others   

                                5.1.4 KITS                            

                                                5.1.4.1 Bisulfite Conversion KITS               

                                                5.1.4.2 Chip-Sequence KITS        

                                                5.1.4.3 RNA Sequencing KITS     

                                                5.1.4.4 Whole-Genome Amplification KITS          

                                                5.1.4.5 5-HMC and 5-MC Analysis KITS   

                                                5.1.4.6 Others   

                                5.1.5 Reagents                 

                                                5.1.5.1 Antibodies           

                                                5.1.5.2  buffers 

                                                5.1.5.3 Histones               

                                                5.1.5.4 Magnetic Beads

                                                5.1.5.5 Primers

                                                5.1.5.6 Others   

                                5.1.6  Y-o-Y Growth Analysis, By Product                              

                                5.1.7 Market Attractiveness Analysis, By Product                             

                                5.1.8  Market Share Analysis, By Product                              

                5.2 Research Area                                           

                                5.2.1 Introduction                           

                                5.2.2 Developmental Biology                     

                                5.2.3 Oncology                 

                                5.2.4 Drug Delivery                         

                                5.2.5 Y-o-Y Growth Analysis, By Research Area                  

                                5.2.6 Market Attractiveness Analysis, By Research Area                

                                5.2.7 Market Share Analysis, By Research Area                  

6. Geographical Analysis                                                              

                6.1 Introduction                                               

                                6.1.1 Regional Trends                    

                                6.1.2 Impact Analysis                     

                                6.1.3 Y-o-Y Growth Analysis                        

                                                6.1.3.1 By Geographical Area     

                                                6.1.3.2 By Product           

                                                6.1.3.3 By Research Area             

                                6.1.4  Market Attractiveness Analysis                     

                                                6.1.4.1 By Geographical Area     

                                                6.1.4.2 By Product           

                                                6.1.4.3 By Research Area             

                                6.1.5  Market Share Analysis                      

                                                6.1.5.1 By Geographical Area     

                                                6.1.5.2 By Product           

                                                6.1.5.3 By Research Area             

                6.2 U.K                                 

                6.3 Spain                                             

                6.4 Germany                                     

                6.5 Italy                                               

                6.6 France                                          

7.Strategic Analysis                                                        

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8.Market Leaders' Analysis                                                         

                8.1 Abcam plc.                                  

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Financial analysis                  

                                8.1.4 Recent Developments                       

                                8.1.5 SWOT analysis                       

                                8.1.6 Analyst View                          

                8.2 Illumina, Inc.                                              

                8.3 QIAGEN N.V.                                             

                8.4 Merck & Co.                                               

                8.5 New England Biolabs, Inc.                                    

                8.6 Zymo Research Corporation                                

                8.7 Sigma-Aldrich Corporation                                   

                8.8 Thermo Fisher Scientific, Inc.                                              

                8.9 Active Motif                                               

                8.10 Diagenode, Inc.                                      

9.Competitive Landscape                                                            

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10.Market Outlook and Investment Opportunities                                                          

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

 

  1. Europe Epigenetics Market, By Product, From 2020 to 2025 (USD Million)
  2. Europe Enzymes Market, By Region, From 2020 to 2025 (USD Million)
  3. Europe Instruments & Consumables Market, By Region, From 2020 to 2025 (USD Million)
  4. Europe KITS Market, By Region, From 2020 to 2025 (USD Million)
  5. Europe Reagents Market, By Region, From 2020 to 2025 (USD Million)
  6. Europe Epigenetics Market, By Research area, From 2020 to 2025 (USD Million)
  7. Europe Developmental Biology Market, By Region, From 2020 to 2025 (USD Million)
  8. Europe Oncology Market, By Region, From 2020 to 2025 (USD Million)
  9. Europe Drug Delivery Market, By Region, From 2020 to 2025 (USD Million)
  10. U.K. Epigenetics Market, By Product, From 2020 to 2025 (USD Million)
  11. U.K. Epigenetics Market, By Research area, From 2020 to 2025 (USD Million)
  12. Germany Epigenetics Market, By Product, From 2020 to 2025 (USD Million)
  13. Germany Epigenetics Market, By Research area, From 2020 to 2025 (USD Million)
  14. France Epigenetics Market, By Product, From 2020 to 2025 (USD Million)
  15. France Epigenetics Market, By Research area, From 2020 to 2025 (USD Million)
  16. Italy Epigenetics Market, By Product, From 2020 to 2025 (USD Million)
  17. Italy Epigenetics Market, By Research area, From 2020 to 2025 (USD Million)
  18. Spain Epigenetics Market, By Product, From 2020 to 2025 (USD Million)
  19. Spain Epigenetics Market, By Research area, From 2020 to 2025 (USD Million)
  20. Europe Epigenetics Market, By Enzymes, From 2020 to 2025 (USD Million)
  21. Europe DNA-Modifying Enzymes Market, By Region, From 2020 to 2025 (USD Million)
  22. Europe Protein-Modifying Enzymes Market, By Region, From 2020 to 2025 (USD Million)
  23. Europe RNA-Modifying Enzymes Market, By Region, From 2020 to 2025 (USD Million)
  24. U.K. Epigenetics Market, By Enzymes, From 2020 to 2025 (USD Million)
  25. Germany Epigenetics Market, By Enzymes, From 2020 to 2025 (USD Million)
  26. France Epigenetics Market, By Enzymes, From 2020 to 2025 (USD Million)
  27. Italy Epigenetics Market, By Enzymes, From 2020 to 2025 (USD Million)
  28. Spain Epigenetics Market, By Enzymes, From 2020 to 2025 (USD Million)
  29. Europe Epigenetics Market, By Instruments & Consumables , From 2020 to 2025 (USD Million)
  30. Europe Mass Spectrometers Market, By Region, From 2020 to 2025 (USD Million)
  31. Europe Next-Generation Sequencers Market, By Region, From 2020 to 2025 (USD Million)
  32. Europe QPCR Market, By Region, From 2020 to 2025 (USD Million)
  33. Europe Sonicators Market, By Region, From 2020 to 2025 (USD Million)
  34. Europe Others Market, By Region, From 2020 to 2025 (USD Million)
  35. U.K. Epigenetics Market, By Instruments & Consumables , From 2020 to 2025 (USD Million)
  36. Germany Epigenetics Market, By Instruments & Consumables , From 2020 to 2025 (USD Million)
  37. France Epigenetics Market, By Instruments & Consumables , From 2020 to 2025 (USD Million)
  38. Italy Epigenetics Market, By Instruments & Consumables , From 2020 to 2025 (USD Million)
  39. Spain Epigenetics Market, By Instruments & Consumables , From 2020 to 2025 (USD Million)
  40. Europe Epigenetics Market, By KITS, From 2020 to 2025 (USD Million)
  41. Europe Bisulfite Conversion KITS Market, By Region, From 2020 to 2025 (USD Million)
  42. Europe Chip-Sequence KITS Market, By Region, From 2020 to 2025 (USD Million)
  43. Europe RNA Sequencing KITS Market, By Region, From 2020 to 2025 (USD Million)
  44. Europe Whole-Genome Amplification KITS Market, By Region, From 2020 to 2025 (USD Million)
  45. Europe 5-HMC and 5-MC Analysis KITS Market, By Region, From 2020 to 2025 (USD Million)
  46. Europe Others Market, By Region, From 2020 to 2025 (USD Million)
  47. U.K. Epigenetics Market, By KITS, From 2020 to 2025 (USD Million)
  48. Germany Epigenetics Market, By KITS, From 2020 to 2025 (USD Million)
  49. France Epigenetics Market, By KITS, From 2020 to 2025 (USD Million)
  50. Italy Epigenetics Market, By KITS, From 2020 to 2025 (USD Million)
  51. Spain Epigenetics Market, By KITS, From 2020 to 2025 (USD Million)
  52. Europe Epigenetics Market, By Reagent, From 2020 to 2025 (USD Million)
  53. Europe Antibodies Market, By Region, From 2020 to 2025 (USD Million)
  54. Europe buffers Market, By Region, From 2020 to 2025 (USD Million)
  55. Europe Histones Market, By Region, From 2020 to 2025 (USD Million)
  56. Europe Magnetic Beads Market, By Region, From 2020 to 2025 (USD Million)
  57. Europe Primers Market, By Region, From 2020 to 2025 (USD Million)
  58. Europe Others Market, By Region, From 2020 to 2025 (USD Million)
  59. U.K. Epigenetics Market, By Reagent, From 2020 to 2025 (USD Million)
  60. Germany Epigenetics Market, By Reagent, From 2020 to 2025 (USD Million)
  61. France Epigenetics Market, By Reagent, From 2020 to 2025 (USD Million)
  62. Italy Epigenetics Market, By Reagent, From 2020 to 2025 (USD Million)
  63. Spain Epigenetics Market, By Reagent, From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample